Clinical impact of Ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19B-cell repopulation.

Mult Scler Relat Disord

Royal Stoke MS Centre, University Hospitals of North Midlands NHS Trust, Royal Stoke University Hospital, Newcastle Road, Stoke-on-Trent ST4 6QG, United Kingdom.

Published: November 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474870PMC
http://dx.doi.org/10.1016/j.msard.2021.103287DOI Listing

Publication Analysis

Top Keywords

clinical impact
4
impact ocrelizumab
4
ocrelizumab extended
4
extended interval
4
interval dosing
4
dosing covid-19
4
covid-19 pandemic
4
pandemic associations
4
associations cd19b-cell
4
cd19b-cell repopulation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!